347 related articles for article (PubMed ID: 21139350)
1. Induction of a Th-1-biased IgG subclass response against equine herpesvirus type 1 in horses previously infected with type 4 virus.
Bannai H; Tsujimura K; Kondo T; Nemoto M; Yamanaka T; Sugiura T; Maeda K; Matsumura T
J Vet Med Sci; 2011 Apr; 73(4):535-9. PubMed ID: 21139350
[TBL] [Abstract][Full Text] [Related]
2. IgG antibody subclass response against equine herpesvirus type 4 in horses.
Mizukoshi F; Maeda K; Hamano M; Iwata H; Matsumura T; Kondo T; Sugiura T
Vet Immunol Immunopathol; 2002 Sep; 88(1-2):97-101. PubMed ID: 12088649
[TBL] [Abstract][Full Text] [Related]
3. Mitigation of pyrexia by a Th-1-biased IgG subclass response after infection with equine herpesvirus type 1 in horses pre-immunized with inactivated vaccine.
Bannai H; Tsujimura K; Kondo T; Nemoto M; Yamanaka T; Sugiura T; Kato T; Maeda K; Matsumura T
J Vet Med Sci; 2012 Jun; 74(6):791-5. PubMed ID: 22230983
[TBL] [Abstract][Full Text] [Related]
4. Immunological correlates of vaccination and infection for equine herpesvirus 1.
Goodman LB; Wimer C; Dubovi EJ; Gold C; Wagner B
Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
[TBL] [Abstract][Full Text] [Related]
5. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
7. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
[TBL] [Abstract][Full Text] [Related]
8. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
Learmonth GS; Love DN; Wellington JE; Gilkerson JR; Whalley JM
Arch Virol; 2002 Mar; 147(3):607-15. PubMed ID: 11958459
[TBL] [Abstract][Full Text] [Related]
9. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
[TBL] [Abstract][Full Text] [Related]
10. Development of a peptide ELISA for discrimination between serological responses to equine herpesvirus type 1 and 4.
Lang A; de Vries M; Feineis S; Müller E; Osterrieder N; Damiani AM
J Virol Methods; 2013 Nov; 193(2):667-73. PubMed ID: 23928223
[TBL] [Abstract][Full Text] [Related]
11. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
[TBL] [Abstract][Full Text] [Related]
12. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
[TBL] [Abstract][Full Text] [Related]
13. Virological and serological investigation of Equid herpesvirus 1 infection in New Zealand.
Dunowska M; Gopakumar G; Perrott MR; Kendall AT; Waropastrakul S; Hartley CA; Carslake HB
Vet Microbiol; 2015 Apr; 176(3-4):219-28. PubMed ID: 25666453
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
Patel JR; Didlick S; Bateman H
Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
[TBL] [Abstract][Full Text] [Related]
15. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
Bannai H; Nemoto M; Tsujimura K; Yamanaka T; Kokado H; Kondo T; Matsumura T
Vet Microbiol; 2018 Aug; 222():18-24. PubMed ID: 30080668
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
17. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
[TBL] [Abstract][Full Text] [Related]
18. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
Virology; 2019 May; 531():219-232. PubMed ID: 30928700
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
[TBL] [Abstract][Full Text] [Related]
20. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
Stokes A; Corteyn AH; Murray PK
Res Vet Sci; 1991 Sep; 51(2):141-8. PubMed ID: 1664967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
